Indivior a Buy as US Opiate Addiction Treatment Demand Soars

Updated:

Indivior (INDV), the speciality pharmaceutical company, is not particularly well known, but perhaps it should be. Its major claim to fame – and the main driver of earnings – is its market-leading treatment for addiction to opioid-based drugs, Sublocade. The company is headquartered in the US although it is listed on the London Stock Exchange. […]